Corporate Governance

Committee Composition

Committees & Charters

View the Audit Committee Charter View the Compensation Committee Charter View the Nominating / Corporate Governance Committee Charter View the Science and Medical Technology Committee Charter

Governance Documents

View the Corporate Governance Guidelines

Ethics Compliance


The Board of Directors of Neurocrine Biosciences has adopted a Code of Business Conduct and Ethics applicable to employees, directors, consultants, and vendors, a link to which can be found on this page. The Board has also established an ethics hotline for reporting potential violations of this Code.

If you have any questions or concerns, you can contact the Neurocrine Ethics Hotline at (800) 688-2908 or visit NeurocrineEthics.com.

View the Code of Business Conduct and Ethics View the Supplier Code of Conduct View the Policy for Recoupment of Incentive Compensation View the Neurocrine Comprehensive Compliance Program View the Declaration of Compliant Interactions with Healthcare Providers View the Political Contributions and Expenditures Policy SEC Filings

Vermont Prescriber Information


Notice to Vermont Prescribers. The Vermont “Pharmaceutical Marketer Price Disclosure Law (33 V.S.A. 2005a),” requires pharmaceutical marketers to disclose to Vermont doctors and other prescribers the prices of drugs they market as well as the prices of other drugs in the same therapeutic class. This information for Neurocrine Biosciences, Inc. products is provided.

View the INGREZZA® (valbenazine) Capsules Long Form View the INGREZZA® Short Form View the CRENESSITY™ (crinecerfont) Capsules Long Form View the CRENESSITY™ Short Form
Resources

You are leaving
Neurocrine.com

Exit Site